{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:01:03Z","timestamp":1748404863256,"version":"3.41.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,23]]},"abstract":"<jats:p>Patients with cardioembolic ischemic stroke are commonly prescribed direct oral anticoagulants (DOACs), such as dabigatran (a direct thrombin inhibitor) and factor Xa inhibitors (e.g., apixaban and rivaroxaban), or warfarin to reduce the risk of recurrent stroke. A major concern in anticoagulant therapy is the risk of intracerebral hemorrhage, which is associated with a high mortality rate. Cerebral microbleeds (MBs), small asymptomatic brain hemorrhages detectable by susceptibility-weighted imaging (SWI) on magnetic resonance imaging (MRI), are associated with increased hemorrhagic stroke risk. This study evaluated the incidence of new MBs during 1 year of anticoagulation therapy in patients after cardioembolic stroke. Patients indicated for anticoagulant therapy after cardioembolic stroke and monitored in the cerebrovascular outpatient clinic of our department underwent brain MRI at baseline and after 1 year of therapy. The occurrence of new MBs was assessed using SWI sequences. MBs were categorized based on location into 3 groups: deep (dMBs), lobar (lMBs), and infratentorial (iMBs). A total of 79 patients were included, 53 of whom were male (67.1%), with a median age of 71 years (IQR: 64\u201376). The majority of patients (n\u2005=\u200550, 63.3%) were treated with apixaban, 16 patients (20.3%) with dabigatran, and 13 patients (16.5%) with warfarin. Baseline MRI revealed MBs in 17 patients (21.5%), including dMBs in 2, lMBs in 16, and iMBs in 2 patients. Follow-up MRI showed new MBs in 8 patients (10.1%), with new dMBs in 1, lMBs in 5, and iMBs in 4 patients. No statistically significant differences were observed in MBs the incidence of new MBs between anticoagulant groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.912). Over 1 year of anticoagulant therapy, new MBs were detected in 10.1% of patients, predominantly in lobar and infratentorial regions. No differences in the incidence of new MBs were identified between the different anticoagulant groups.<\/jats:p>","DOI":"10.1097\/md.0000000000042011","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:00:32Z","timestamp":1748318432000},"page":"e42011","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Newly identified cerebral microbleeds in patients on anticoagulation for secondary stroke prevention"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1969-1832","authenticated-orcid":false,"given":"Tereza","family":"\u0160r\u00e1mkov\u00e1","sequence":"first","affiliation":[{"name":"Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4276-2321","authenticated-orcid":false,"given":"Tom\u00e1\u0161","family":"Va\u0148\u00e1sek","sequence":"additional","affiliation":[{"name":"Department of Radiology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5519-9876","authenticated-orcid":false,"given":"Martin","family":"\u0160r\u00e1mek","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic"},{"name":"Department of Neurology, Military University Hospital Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3159-0958","authenticated-orcid":false,"given":"Petr","family":"Jansk\u00fd","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9369-8434","authenticated-orcid":false,"given":"Kate\u0159ina","family":"Bene\u0161ov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3057-1387","authenticated-orcid":false,"given":"Anna","family":"Ol\u0161erov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4765-3378","authenticated-orcid":false,"given":"Silvia","family":"Kmetonyov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8465-8269","authenticated-orcid":false,"given":"Jaroslava","family":"Paulasov\u00e1-Schwabov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Kl\u00edma","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic"},{"name":"Department of Neurology, Jihlava Hospital, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1871-5385","authenticated-orcid":false,"given":"Luk\u00e1\u0161","family":"Michal","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3010-1174","authenticated-orcid":false,"given":"David","family":"Kala","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5944-5803","authenticated-orcid":false,"given":"Jakub","family":"Ot\u00e1hal","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luk\u00e1\u0161","family":"Mik\u0161\u00edk","sequence":"additional","affiliation":[{"name":"Department of Radiology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ale\u0161","family":"Tomek","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1177\/23969873221100032","article-title":"European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack.","volume":"7","author":"Dawson","year":"2022","journal-title":"Eur Stroke J"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.STR.24.7.987","article-title":"Volume of intracerebral hemorrhage. a powerful and easy-to-use predictor of 30-day mortality.","volume":"24","author":"Broderick","year":"1993","journal-title":"Stroke"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(18)30145-5","article-title":"Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.","volume":"17","author":"Wilson","year":"2018","journal-title":"Lancet Neurol"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1161\/STROKEAHA.110.601922","article-title":"Microbleeds are associated with subsequent hemorrhagic and ischemic stroke in healthy elderly individuals.","volume":"42","author":"Bokura","year":"2011","journal-title":"Stroke"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1161\/STROKEAHA.114.005151","article-title":"Incidence of symptomatic hemorrhage in patients with lobar microbleeds.","volume":"45","author":"Van Etten","year":"2014","journal-title":"Stroke"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1212\/WNL.0000000000004704","article-title":"Brain microbleeds, anticoagulation, and hemorrhage risk: meta-analysis in stroke patients with AF.","volume":"89","author":"Charidimou","year":"2017","journal-title":"Neurology"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/jnen\/nlaa082","article-title":"Mechanisms of cerebral microbleeds.","volume":"79","author":"Wadi","year":"2021","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10 Suppl","key":"R8-20250527","first-page":"S103","article-title":"Prevalence and risk factors of cerebral microbleeds: an update of the rotterdam scan study.","volume":"41","author":"Poels","year":"2010","journal-title":"Stroke"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1161\/STROKEAHA.120.030300","article-title":"Microbleeds and outcome in patients with acute ischemic stroke and atrial fibrillation taking anticoagulants.","volume":"51","author":"Choi","year":"2020","journal-title":"Stroke"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1474-4422(19)30197-8","article-title":"Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.","volume":"18","author":"Wilson","year":"2019","journal-title":"Lancet Neurol"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/STROKEAHA.109.568469","article-title":"MRI detection of new microbleeds in patients with ischemic stroke: five-year cohort follow-up study.","volume":"41","author":"Gregoire","year":"2010","journal-title":"Stroke"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"e25836","DOI":"10.1097\/MD.0000000000025836","article-title":"New cerebral microbleeds in AF patients on non-vitamin K oral anticoagulants or warfarin: one-year follow-up.","volume":"101","author":"Zhuang","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.02.018","article-title":"Non-vitamin K antagonist oral anticoagulants do not increase cerebral microbleeds.","volume":"24","author":"Saito","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ahj.2016.03.019","article-title":"Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study.","volume":"178","author":"O\u2019Donnell","year":"2016","journal-title":"Am Heart J"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.amjcard.2022.03.050","article-title":"Comparison of dabigatran versus warfarin treatment for prevention of new cerebral lesions in valvular atrial fibrillation.","volume":"175","author":"Cho","year":"2022","journal-title":"Am J Cardiol"},{"key":"R16-20250527","first-page":"123","article-title":"Pharmacogenetic algorithm for predicting daily dose of warfarin in Caucasian patients of Czech origin.","volume":"36","author":"Tomek","year":"2021","journal-title":"Drug Metab Pers Ther"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000350407","article-title":"The bleeding risk during warfarin therapy is associated with the number of variant alleles of CYP2C9 and VKORC1 genes.","volume":"125","author":"Tomek","year":"2013","journal-title":"Cardiology"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke definitions for use in a multicenter clinical trial.","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging.","volume":"149","author":"Fazekas","year":"1987","journal-title":"AJR Am J Roentgenol"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1161\/STROKEAHA.108.526996","article-title":"Improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS).","volume":"40","author":"Cordonnier","year":"2009","journal-title":"Stroke"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1474-4422(09)70013-4","article-title":"Cerebral microbleeds: a guide to detection and interpretation.","volume":"8","author":"Greenberg","year":"2009","journal-title":"Lancet Neurol"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"e0238456","DOI":"10.1371\/journal.pone.0238456","article-title":"Oral anticoagulant use and the development of new cerebral microbleeds in cardioembolic stroke patients with atrial fibrillation.","volume":"15","author":"Umemura","year":"2020","journal-title":"PLoS One"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.clineuro.2013.03.004","article-title":"New cerebral microbleeds in ischemic stroke patients on warfarin treatment: two-year follow-up.","volume":"115","author":"Orken","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.03.050","article-title":"Effectiveness of nonvitamin K antagonist oral anticoagulants and warfarin for preventing further cerebral microbleeds in acute ischemic stroke patients with nonvalvular atrial fibrillation and at least one microbleed: CMB-NOW multisite pilot trial.","volume":"28","author":"Yokoyama","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1212\/01.wnl.0000194266.55694.1e","article-title":"Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications.","volume":"66","author":"Koennecke","year":"2006","journal-title":"Neurology"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1136\/jnnp-2013-306992","article-title":"Stroke in Asia: geographical variations and temporal trends.","volume":"85","author":"Mehndiratta","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s00415-019-09572-x","article-title":"Use of anticoagulant therapy and cerebral microbleeds: a systematic review and meta-analysis.","volume":"268","author":"Cheng","year":"2021","journal-title":"J Neurol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:00:36Z","timestamp":1748318436000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":28,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042011","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]}}}